Dairy Research Cluster 2 (DRC2)

Animal 

Prevention of infection at drying-off by stimulation of mammary gland immunity

evelop a biological response modifier that will promote a sustained immunity of the mammary teat and protect the gland from invading pathogens.

    Results

    • Chitosan is a molecule derived from the shell structure of crustaceans and shellfish and significantly increased the number of immune cells in the udder and levels of compounds associated with involution, while stimulating local immune response during dry-off period.
    • The chitosan hydrogel function is not affected by the teat sealant when used together. In addition, the use of a chitosan-based hydrogel in combination with teat sealant may combine the benefits of stimulating the immune response while generating a physical barrier between the teat and outside environment.
    • A hydrogel made up of chitosan can be used in combination with existing mastitis-preventing tools during dry off. This method could potentially decrease prophylactic antibiotics while decreasing the risk of developing new mastitis infections during the dry-off period.

    Research Team

    • Pierre Lacasse (Principal Investigator, Sherbrooke RDC – AAFC)
    • Samuel Lanctôt (MSc candidate, UMcGill)
    • Xin Zhao (collaborator, UMcGill)
    • Patrick Fustier (collaborator, CRDA-AAFC) Not in photo

    Quarter-based selective dry-cow treatment using on-farm diagnostic tool

    Decrease the use of antibiotics at drying-off by 50 % while maintaining udder health.

      Results

      • With selectve dry cow therapy, infected cows may be treated with an antimicrobial only or with a combina-
        tion of antimicrobial and a teat sealant at the end of lactation, while uninfected cows receive only a teat
        sealant.
      •  Introducing such a treatment strategy will, of course, generate new costs, mainly costs for diagnostic tests
        and extra labor for sampling and conducting the test (for on-farm tests). On the other hand, less antimicrobials are used and costs for drugs and labor for administering drugs are saved.
      • Selective dry cow therapy is one potential strategy for achieving a more judicious use of antimicrobials.

      Research Team

      • Jean-Philippe Roy (Principal Investigator, UMontréal)
      • Fidèle Kabera (MSc candidate, UMontréal)     
      • Greg Keefe (collaborator, UPEI)
      • Simon Dufour (collaborator, UMontréal)

      Pathogen and cow characteristics associated with recurrence of clinical mastitis

      Predict more accurately the probability of a recurrent clinical mastitis event following a first clinical mastitis case and adjust the management and culling decisions accordingly.

        Results

        • Important risk factors for CM recurrence were identified, these included: parity (i.e. higher risk in older cows), a higher milk production, pathogen species involved in the preceding case, and whether a bacteriological cure was observed following the preceding case.
        • The most important effects of recurrent CM were identified: the milk yield reduction following a recurrent CM case, which was reported to be similar to that of the first CM case, and the increased risk of culling and mortality, which were reported to surpass those of first CM cases.

        Research Team

        • Simon Dufour (Principal Investigator, UMontréal)
        • Ève-Marie Lavallée-Bourget (Undergraduate student, UMontréal)
        • Hossein Jamali (MSc candidate, UMontréal)

        Not in photo:

        • Mario Jacques (collaborator, UMontréal)
        • François Malouin (collaborator, USherbrooke)
        •  Herman Barkema (collaborator, UCalgary)
        • Henrik Stryhn (collaborator, UPEI)

        Pathogens

        Predicting persistence and clinical expression of S.aureus infections using molecular characterization

        Confirm that the identification of virulence genes and biofilm production of current strains of S. aureus is a good predictive tool to estimate duration and expression of these strains. Encourage the use of this diagnostic method before treating or culling cows.

          Results 

          S. aureus phenotypic and genotypic characteristics were evaluated to predict the duration of IMI. We found that some characteristics of the pathogen including determination of the spa type genes helps to predict duration of infection and the clinical or subclinical outcome of S. aureus IMIs. However, the bovine host genetic and immune status, and the influence of the environment and of management practices are also factors that could help predicting duration of infection. 

          Research Team

          • Sébastien Pichette-Jolette (MSc candidate, USherbrooke)
          • Abdelhamid Asli (undergraduate student, USherbrooke)
          • Jean-Philippe Roy (Principal Investigator, UMontréal)

          Not in photo:

          • François Malouin (collaborator, USherbrooke)
          • Greg Keefe (collaborator, UPEI)

          Validation of MALDI-TOF diagnostic equipment for CNS speciation and development of intramammary infection risk models

          Build and test a spectral library for speciation of CNS and investigate the impact of species-specific CNS infection on development of new major pathogen infection.

            Results

            • Research-validated spectroscopy-based diagnostic methods improved the species-specificity and accuracy of pathogen diagnosis.
            • Sixteen custom reference spectra which covered 10 different species of CNS were developed to enhance the performance of MALDI-ToF MS for CNS species identification. These custom reference spectra are being made available for use by both diagnostic laboratories and researchers that are adopting MALDI-ToF MS for bovine mastitis microbial identification and are improving the accuracy of mastitis diagnosis around the world.
            • According to the results of analysis on 5,827 isolates, Staphylococcus chromogenesrepresented 48.2% of the CNS, followed by S. simulans(16.7%), S. xylosus(11.2%), S. haemolyticus(7.8%), and S. epidermidis(4.0%).

            Research Team

            • Jean-Philippe Roy (collaborator, UMontréal)
            • Marcelo Chaffer (collaborator, UPEI)
            • Greg Keefe (PrincipaI Investigator, UPEI)

            Not in photo:

            • Marguerite Cameron (post-doctoral fellow, UPEI) and collaborators: Sarne De Vliegher (Ghent University),
            • Kristen Reyher (UBristol)
            • Catherine Anne Muckle (UPEI)
            • Jeffrey Lewis (UPEI)

            Antibiofilm molecules active against S. aureus and coagulase-negative staphylococci isolates

            Identify mechanism(s) of action and spectrum of activity of antibiofilm molecules of S. simulans and S. chromogenes.
            Evaluate the effect of these molecules on the ability of staphylococcal isolates to cause persistent intramammary infections.

              Results

              To this day, several intriguing molecules have been isolated and shown to hinder biofilm formation. Their exact nature and mechanism of action remains to be identified.

              Research Team

              • Abdelhamid Asli (MSc candidate, USherbrooke)
              • Coralie Goetz (PhD, UMontréal)
              • Mario Jacques (Principal Investigator, UMontréal)
              • François Malouin (collaborator, USherbrooke)
              • Yannick Tremblay (Postdoctoral fellow, UMontréal

               

              Novel treatment for staphylococci intramammary infections

              Improve stability and potency of a new antibiotic | Evaluate activity against S. aureus and CNS  |  Evaluate the safety in dairy cows

                Results

                • New knowledge on efficacy of various molecules of a new drug target for S. aureus were acquired.
                • The last antimicrobial molecule with a new mode of action was commercialized in the eighties. This is, therefore, a very important discovery that could have a tremendous impact in veterinary and, perhaps, human medicine. The initial discovery of this molecule was voted one of the 10 discoveries of the year in 2010 by the ‘’Quebec Science’’ magazine. We were able to further refine the molecule to obtain a more stable molecule that could be commercially marketed.

                Research Team

                • Céline Ster (Postdoc Fellow, researcher, USherbrooke)
                • François Malouin (Principal Investigator, USherbrooke)
                • Véronique Belley (MSc candidate, USherbrooke)

                Not pictured :

                • Eric Marsault (collaborator, USherbrooke)
                • Pierre Lacasse (collaborator, CRD de Sherbrooke-AAC)
                • Charles Isabelle and Natasa Obradovic (students, USherbrooke)

                Environment

                What type of housing systems provide the most suitable environment for cow comfort as well as udder health?

                Researchers evaluated different housing systems that enable cows to thrive in a clean and comfortable environment and examined its impact on mastitis pervalence.

                  Results

                  • Bedding management can have a profound impact on cow hygiene and bacterial concentrations in the bedding substrates, which in turn may affect mastitis risk. The most important factors affecting this relationship include the addition of new bedding, how often the stalls are scraped, housing type, milking system, and herd size. We observed that, on commercial farms, cows prefer to lie down in cleaner and more comfortable environments.
                  • Finally, cows with low Body Condition, which were at greater risk of having high SCC, were also the highest producing, had poorest lower leg hygiene, and spent the most time standing.

                  Research Team

                  • Jean-Philippe Roy (Collaborator, UMontréal)
                  • Herman Barkema (Collaborator, UCalgary)
                  • Trevor DeVries (Principal Investigator, UGuelph)
                  • Dave Kelton (Collaborator, UGuelph)
                  • Greg Keefe (collaborator, UPEI)
                  • Ivelisse Robles (PhD candidate, UGuelph)

                  Not pictured:  

                  • Marina von Keyserlingk (collaborator, UBC)

                  Impact of management practices on antimicrobial resistance

                  Determine the prevalence of antimicrobial resistance in CNS isolates, determine the relationship between antimicrobial use and resistance and investigate resistance gene transfer between CNS and S. aureus isolates.

                    Results

                    • Selective dry-cow treatment has been shown to reduce the amount of antimicrobials used, without being the method most correlated with antimicrobial resistance.
                    • Systemic use of antimicrobials is associated with a higher prevalence of resistance, compared to local antimicrobial administration.
                    • Limiting the use of antimicrobials, as well as their judicious use will contribute to slowing down the emergence of antimicrobial resistance.

                    Research Team

                    • Christopher Luby (collaborator, USaskatchewan)
                    • Jeroen De Buck (collaborator, UCalgary)
                    • Herman Barkema (Principal Investigator, UCalgary)
                    • Diego Nóbrega (PhD candidate, UCalgary)
                    • Larissa Condas (MSc candidate, UCalgary)

                    Not pictured: 

                    • Vineet Saini (collaborator, UCalgary)

                    Economic impact of mastitis control practices

                    Identify factors facilitating or inhibiting adoption of best management practices.
                    Investigate producer perceptions of risks, preferences for new information, and decision process regarding adoption of new practices.

                      Results

                      The cost of mastitis in a herd represent $660 per cow

                      Half of these costs are associated with subclinical mastitis

                      • 72 % are losses incured due to drop of milk production in affected cows
                      • 25 % associated with increased culling risk

                      A third of these costs are associated with clinical mastitis :

                      • 34 % caused by reduced milk production
                      • 48 % associated with increased culling and mortality risk
                      •  The average cost of clinical mastitis is $744

                        Research Team

                        • Simon Dufour (Principal Investigator, UMontréal)
                        • Greg Keefe (collaborator, UPEI)
                        • Kehar Singh (collaborator, UPEI)
                        • Herman Barkema (collaborator, UCalgary)
                        • Dave Kelton (collaborator, UGuelph)
                        • Mahjoob Aghamohammadi (MSc candidate, UMontréal)

                        Obstacles to adoption of better management practices

                        Identify factors facilitating or inhibiting adoption of best management practices.
                        Investigate producer perceptions of risks, preferences for new information, and decision process regarding adoption of new practices.

                          Results

                          • Producers' ideas and perception of what it means to produce quality milk with low SCC influence their degree of motivation for implementing mastitis prevention paractices.
                          • Certain routines and habits are hard to break; dairy farms producing good quality milk by definition (i.e. SCC less than 400 000 cells/ml) will probably see no reason to change or adapt their practices unless they are motivated to do so, either through incentives or penalties.
                          • The majority of producers agree with the popular phrase: "If it ain't broke, don't fix it!"

                          Research Team

                          • Simon Dufour (collaborator, UMontréal)
                          • Greg Keefe (collaborator, UPEI)
                          • Herman Barkema (collaborator, UCalgary)
                          • Gale West (collaborator, U Laval)
                          • Dave Kelton (Principal Investigator, UGuelph)
                          • Alex Watters (PhD candidate, UGuelph)
                          • Emilie Belage (candidate MSc, UGuelph)

                          Not pictured:

                          • Jason Coe (collaborator, UGuelph)